SecBot SecBot
8-K ·Filed May 5, 2026

WAT

WATERS CORP /DE/
BULLISH
Impact 8/10
Horizonweeks Processed6mo ago SEC0001193125-26-204955
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The strong beat and raised guidance confirm accelerating momentum from both organic growth and the transformative BDS acquisition. Watch for Q2 guidance of $2.95-$3.05 adjusted EPS (flat to +3.4% YoY) as the integration progresses; the stock should re-rate higher on the raised full-year outlook. Monitor free cash flow trajectory in coming quarters as working capital normalizes.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$342.75
T+0 close · May 5, 2026 · via day close
Latest settled
+10.96%
T+60 · $380.30
Vs SPY
+8.22%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 5 $342.75entry
  2. T+1 · 6mo ago +1.98%α +0.59% · $349.53
  3. T+5 · 6mo ago +2.76%α +0.78% · $352.21
  4. T+20 · 6mo ago +8.51%α +3.56% · $371.93
  5. T+60 · 4mo ago +10.96%α +8.22% · $380.30

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Waters reported Q1 2026 total revenue of $1.267B, well above the $1.20B consensus, driven by $747M in organic revenue (up 13% as reported, 11% constant currency) and $520M from the newly acquired BDS business. Adjusted EPS of $2.70 grew 20% YoY, beating the $2.31 consensus by 16.9%. The company raised full-year 2026 adjusted EPS guidance to $14.40-$14.60 and organic constant currency growth to 6.5%-8.0%, signaling strong momentum from the acquisition and organic execution.

Key Financial Metrics

EPS
$2.70
est $2.31 · +16.9%
Revenue
$1.3B
est $1.2B · +5.6% · +91.4% YoY
Rating
strong beat
Guidance
$6.405B-$6.455B
raised
Free Cash Flow
-$42.0M

Key Facts

  • Total reported revenue of $1.267B exceeded the high end of guidance by $56M and consensus of $1.20B.
  • Organic revenue grew 13% as reported and 11% in constant currency, exceeding the high end of guidance by 200 bps.
  • Adjusted EPS of $2.70 grew 20% YoY, beating consensus of $2.31 by 16.9%.
  • Biosciences and Diagnostic Solutions (BDS) contributed $520M in revenue since the Feb 9 acquisition close, $40M above guidance.
  • Full-year 2026 adjusted EPS guidance raised to $14.40-$14.60 (from $14.30-$14.50), representing 10%-11% YoY growth.
  • Full-year 2026 organic constant currency revenue growth guidance raised to 6.5%-8.0% (from 5.5%-7.0%).
  • GAAP diluted EPS was ($0.87) due to $251M in acquisition-related purchase accounting charges (intangibles amortization and inventory step-up).
  • Free cash flow was negative ($42M) in Q1 vs positive $234M in the prior year, impacted by working capital build and BDS integration.

Financial Impact

Adjusted EPS beat consensus by $0.39 (16.9%); total revenue beat consensus by ~$67M (5.6%); guidance raised for both revenue and EPS.

revenueepsguidancecashFlow

Risk Factors

  • Integration risk from the large BDS acquisition; $5.2B in debt on the balance sheet increases financial leverage.
  • GAAP losses from purchase accounting charges will persist through 2026, potentially confusing headline readers.
  • Q2 adjusted EPS guidance of $2.95-$3.05 implies only flat to +3.4% YoY growth, a deceleration from Q1's 20% growth.

Market Snapshot

Exchange
NYSE
Sector
Laboratory Analytical Instruments
Analyst Consensus
57% bullish (28 analysts)

Investment Themes

Industrials & Manufacturing

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-204955
Document: d131836d8k.htm0001193125-26-204955
Document: 0001193125-26-204955-index-headers.html0001193125-26-204955
Document: 0001193125-26-204955-index.html0001193125-26-204955
Document: 0001193125-26-204955.txt0001193125-26-204955
8-K Data (Synthetic)0001193125-26-204955

Track record

7 reports on WAT

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +18.30% at T+60 after the Aug 4, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 6, 20269d ago 3 Neutral 2/10 Entry $476.70 Now $453.53 −4.86% due Nov 16
  2. Nov 3, 202613d ago 8-K Bullish 6/10 Entry $459.90 to $475.52 Now $453.53 −1.39% ▲ +3.40% +3.98% vs SPY
  3. Nov 3, 202613d ago Press Release Bullish 6/10 Entry $459.90 to $475.52 Now $453.53 −1.39% ▲ +3.40% +3.98% vs SPY
  4. Aug 21, 202612w ago 8-K Neutral 3/10 Entry $410.70 to $414.69 Now $453.53 +10.43% ▲ +0.97% +0.50% vs SPY
  5. Aug 4, 202614w ago Press Release Bullish 7/10 Entry $396.08 to $415.00 Now $453.53 +14.50% ▲ +4.78% +4.88% vs SPY
  6. Jun 25, 202620w ago Institutional Cluster Neutral 4/10 Entry $376.89 to $378.13 Now $453.53 +20.33% ▲ +0.33% −1.23% vs SPY
  7. May 5, 202627w ago 8-K Bullish 8/10 Viewing Entry $342.75 to $352.21 Now $453.53 +32.32% ▲ +2.76% +0.78% vs SPY
Showing 7 of 7

US Market Status

Market Closed · Opens Tue (17h 24m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 5, 2026